WO2019059549A3 - 베타글루칸을 유효성분으로 하는 숙취 해소용 조성물 또는 알코올성 간질환 예방, 개선 또는 치료용 조성물 - Google Patents

베타글루칸을 유효성분으로 하는 숙취 해소용 조성물 또는 알코올성 간질환 예방, 개선 또는 치료용 조성물 Download PDF

Info

Publication number
WO2019059549A3
WO2019059549A3 PCT/KR2018/009974 KR2018009974W WO2019059549A3 WO 2019059549 A3 WO2019059549 A3 WO 2019059549A3 KR 2018009974 W KR2018009974 W KR 2018009974W WO 2019059549 A3 WO2019059549 A3 WO 2019059549A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
glucan
alleviating
preventing
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2018/009974
Other languages
English (en)
French (fr)
Other versions
WO2019059549A2 (ko
Inventor
이종대
류제필
최승인
김제경
장용만
김민지
박은지
양철수
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUEGEN BIOTECH CO Ltd
Original Assignee
GUEGEN BIOTECH CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180101390A external-priority patent/KR102118731B1/ko
Application filed by GUEGEN BIOTECH CO Ltd filed Critical GUEGEN BIOTECH CO Ltd
Priority to CN201880060797.0A priority Critical patent/CN111107854B/zh
Priority to JP2020515651A priority patent/JP7011347B2/ja
Priority to US16/646,854 priority patent/US11154568B2/en
Publication of WO2019059549A2 publication Critical patent/WO2019059549A2/ko
Publication of WO2019059549A3 publication Critical patent/WO2019059549A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

본 발명은 베타글루칸(β-glucan)을 유효성분으로 포함하는 숙취 해소용 조성물 또는 알코올성 간질환 예방, 개선 또는 치료용 조성물에 관한 것이다.
PCT/KR2018/009974 2017-09-19 2018-08-29 베타글루칸을 유효성분으로 하는 숙취 해소용 조성물 또는 알코올성 간질환 예방, 개선 또는 치료용 조성물 Ceased WO2019059549A2 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201880060797.0A CN111107854B (zh) 2017-09-19 2018-08-29 包含β-葡聚糖作为有效成分的宿醉解除用组合物或酒精性肝病预防、改善或治疗用组合物
JP2020515651A JP7011347B2 (ja) 2017-09-19 2018-08-29 ベータグルカンを有効成分とする二日酔い解消用組成物またはアルコール性肝疾患の予防、改善または治療用組成物
US16/646,854 US11154568B2 (en) 2017-09-19 2018-08-29 Composition for relieving hangover or composition for preventing, alleviating or treating alcoholic liver disease, comprising b-glucan as active ingredient

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20170120339 2017-09-19
KR10-2017-0120339 2017-09-19
KR1020180101390A KR102118731B1 (ko) 2017-09-19 2018-08-28 베타글루칸을 유효성분으로 하는 숙취 해소용 조성물 또는 알코올성 간질환 예방, 개선 또는 치료용 조성물
KR10-2018-0101390 2018-08-28

Publications (2)

Publication Number Publication Date
WO2019059549A2 WO2019059549A2 (ko) 2019-03-28
WO2019059549A3 true WO2019059549A3 (ko) 2019-05-09

Family

ID=65809770

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/009974 Ceased WO2019059549A2 (ko) 2017-09-19 2018-08-29 베타글루칸을 유효성분으로 하는 숙취 해소용 조성물 또는 알코올성 간질환 예방, 개선 또는 치료용 조성물

Country Status (1)

Country Link
WO (1) WO2019059549A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7696698B2 (ja) * 2020-06-16 2025-06-23 株式会社神鋼環境ソリューション アセトアルデヒド代謝促進剤
CN117016659B (zh) * 2023-08-23 2025-07-18 广东健明生物科技有限公司 一种具有解酒护肝功效的组合物、压片糖果及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040001827A (ko) * 2002-06-28 2004-01-07 (주)바이오버드 불용성 생리활성물질을 함유한 분산성 조각 젤리타입입자혼입 기능성음료 제조방법
KR100707917B1 (ko) * 2005-12-06 2007-04-13 주식회사 글루칸 베타 글루칸을 유효성분으로 포함하는 간질환 치료용 약학조성물
JP4975947B2 (ja) * 2003-11-12 2012-07-11 一光化学株式会社 健康飲料
KR20130118058A (ko) * 2012-04-19 2013-10-29 권재윤 숙취해소용 식품조성물
KR20180042936A (ko) * 2016-10-19 2018-04-27 휴코스코리아(주) 치마버섯 분리 균사체 배양액을 유효성분으로 함유하는 숙취해소 및 간질환의 예방 및 치료용 약학조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040001827A (ko) * 2002-06-28 2004-01-07 (주)바이오버드 불용성 생리활성물질을 함유한 분산성 조각 젤리타입입자혼입 기능성음료 제조방법
JP4975947B2 (ja) * 2003-11-12 2012-07-11 一光化学株式会社 健康飲料
KR100707917B1 (ko) * 2005-12-06 2007-04-13 주식회사 글루칸 베타 글루칸을 유효성분으로 포함하는 간질환 치료용 약학조성물
KR20130118058A (ko) * 2012-04-19 2013-10-29 권재윤 숙취해소용 식품조성물
KR20180042936A (ko) * 2016-10-19 2018-04-27 휴코스코리아(주) 치마버섯 분리 균사체 배양액을 유효성분으로 함유하는 숙취해소 및 간질환의 예방 및 치료용 약학조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
2016, Retrieved from the Internet <URL:http://m.mt.co.kr/renew/view.html?no=2016082411045844882> *

Also Published As

Publication number Publication date
WO2019059549A2 (ko) 2019-03-28

Similar Documents

Publication Publication Date Title
EP4026835A3 (en) Pd-1/pd-l1 inhibitors
AU2015336400A8 (en) Novel Aminoalkyl benzothiazepine Derivatives And Uses Thereof
BR112018004620A2 (pt) moduladores da expressão de kras
MX389228B (es) Composiciones para tratar el cabello.
AU2018258581A8 (en) RAF-degrading conjugate compounds
NZ731029A (en) An antimicrobial composition
WO2015023976A3 (en) Selective grp94 inhibitors and uses thereof
EP4193993A3 (en) Combinations of cannabinoids and n-acylethanolamines
WO2015142001A3 (ko) 강심 활성을 갖는 화합물 및 이를 함유하는 심부전 예방 또는 치료용 약학적 조성물
WO2017083431A3 (en) Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
MX2022011695A (es) Compuestos para dispositivos opticamente activos.
EP4378535A3 (en) Antibiotic formulations for lower back pain
EP4309732A3 (en) Modulators of pcsk9 expression
IN2015DN03069A (ko)
WO2018191482A3 (en) Methods of treating developmental encephalopathies
WO2016094834A3 (en) A method for treating a complement mediated disorder caused by an infectious agent in a patient
WO2018127612A3 (en) Compositions comprising lespedeza plant extract
GB2568181A (en) Wheat
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
EP4339192A3 (en) Compounds and compositions for the treatment of cancer
EP3295946A4 (en) Composition, containing lithospermi radix extract as active ingredient, for preventing, alleviating, or treating peripheral neuropathy
EP4616848A3 (en) Linezolid formulations
EA202090732A1 (ru) Составы для трансдермального введения
CA3035115C (en) Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof
MX2021004756A (es) Productos de consumo y sistemas de suministro que usan compuestos organolepticos.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18858817

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2020515651

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18858817

Country of ref document: EP

Kind code of ref document: A2